{"id":6880,"date":"2024-04-23T10:34:51","date_gmt":"2024-04-23T08:34:51","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/"},"modified":"2024-04-23T10:34:52","modified_gmt":"2024-04-23T08:34:52","slug":"actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023"},"content":{"rendered":"\n

Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023<\/a><\/p>\n\n

Terapia Farmacol\u00f3gica en el manejo de la obesidad<\/p>\n\n

EDITORIAL DEL PRESIDENTE DE LA SEF:<\/p>\n\n

Fe de Farmacolog\u00eda.<\/a><\/p>\n\n

EDITORIAL DEL DIRECTOR:<\/p>\n\n

El Congreso SEF-40 de Toledo.<\/a><\/p>\n\n

EDITORIALES INVITADAS:<\/p>\n\n

La “Tarjeta naranja” o c\u00f3mo comunicar efectos beneficiosos inesperados de un f\u00e1rmaco.<\/a><\/p>\n\n

La Doble H\u00e9lice de ADN…. \u00bfUna verdad inc\u00f3moda?<\/a><\/p>\n\n

La nanotecnolog\u00eda y su aplicaci\u00f3n en la medicina e investigaci\u00f3n biom\u00e9dica.<\/a><\/p>\n\n

FARMACOTERAPIA:<\/p>\n\n

Terapia farmacol\u00f3gica en el manejo de la obesidad.<\/a><\/p>\n\n

Apuntes hist\u00f3ricos sobre el descubrimiento de los f\u00e1rmacos autorizados en el tratamiento del Trastorno Bipolar (TB).<\/a><\/p>\n\n

Replanteo del uso de AINE en el dolor agudo precoz.<\/a><\/p>\n\n

Immune-based pharmacotherapy for Alzheimer’s disease: A\u03b2-targeting monoclonal antibodies.<\/a><\/p>\n\n

NUEVOS F\u00c1RMACOS<\/p>\n\n

Pegcetacoplan: el primer tratamiento para la DMAE seca aprobado por la FDA.<\/a><\/p>\n\n

La FDA aprueba el uso de la sotagliflozina para prevenir la insuficiencia card\u00edaca en pacientes con diabetes.<\/a><\/p>\n\n

Paxlovid\u00ae (nirmatrelvir\/ritonavir), el primer antiviral oral para el tratamiento de la COVID-19.<\/a><\/p>\n\n

Anakinra para el tratamiento de la COVID-19.<\/a><\/p>\n\n

Anticuerpos dirigidos contra el \u03b2-amiloide para el tratamiento de la enfermedad de Alzheimer.<\/a><\/p>\n\n

Nuevos reg\u00edmenes de dosificaci\u00f3n de la citisina para la terapia de deshabituaci\u00f3n tab\u00e1quica.<\/a><\/p>\n\n

HISTORIA DE LA FARMACOLOG\u00cdA:<\/p>\n\n

Breve historia de la SEF.<\/a><\/p>\n\n

EL F\u00c1RMACO Y LA PALABRA<\/p>\n\n

Un m\u00e9dico sabio (an\u00f3nimo).<\/a><\/p>\n\n

Quiero ser libre insincero (Fernando Pessoa).<\/a><\/p>\n\n

<\/p>\n","protected":false},"featured_media":5726,"template":"","categoria_revista":[118],"class_list":["post-6880","revista","type-revista","status-publish","has-post-thumbnail","hentry","categoria_revista-2023-en"],"acf":[],"yoast_head":"\nActualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023 Terapia Farmacol\u00f3gica en el manejo de la obesidad EDITORIAL DEL PRESIDENTE DE LA SEF: Fe de Farmacolog\u00eda. EDITORIAL DEL DIRECTOR: El Congreso SEF-40 de Toledo. EDITORIALES INVITADAS: La “Tarjeta naranja” o c\u00f3mo comunicar efectos beneficiosos inesperados de un f\u00e1rmaco. La Doble H\u00e9lice de ADN…. \u00bfUna ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-23T08:34:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/10\/Portada-AFT-21_3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"478\" \/>\n\t<meta property=\"og:image:height\" content=\"674\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\\\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Portada-AFT-21_3.jpg\",\"datePublished\":\"2024-04-23T08:34:51+00:00\",\"dateModified\":\"2024-04-23T08:34:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Portada-AFT-21_3.jpg\",\"contentUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/Portada-AFT-21_3.jpg\",\"width\":478,\"height\":674},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revistas\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"contentUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Socesfar\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/socesfar\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023 Terapia Farmacol\u00f3gica en el manejo de la obesidad EDITORIAL DEL PRESIDENTE DE LA SEF: Fe de Farmacolog\u00eda. EDITORIAL DEL DIRECTOR: El Congreso SEF-40 de Toledo. EDITORIALES INVITADAS: La “Tarjeta naranja” o c\u00f3mo comunicar efectos beneficiosos inesperados de un f\u00e1rmaco. La Doble H\u00e9lice de ADN…. \u00bfUna ... Read more","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","article_modified_time":"2024-04-23T08:34:52+00:00","og_image":[{"width":478,"height":674,"url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/10\/Portada-AFT-21_3.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Socesfar","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/10\/Portada-AFT-21_3.jpg","datePublished":"2024-04-23T08:34:51+00:00","dateModified":"2024-04-23T08:34:52+00:00","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/#primaryimage","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/10\/Portada-AFT-21_3.jpg","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2023\/10\/Portada-AFT-21_3.jpg","width":478,"height":674},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-21-no-3-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 21, n\u00ba 3, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":1,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6880\/revisions"}],"predecessor-version":[{"id":6881,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/6880\/revisions\/6881"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media\/5726"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=6880"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=6880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}